Author
Listed:
- Kamilla Kolding Bendixen
(PentaBase A/S
University of Southern Denmark)
- Maria Mindegaard
(PentaBase A/S)
- Samantha Epistolio
(Institute of Pathology, Ente Ospedaliero Cantonale (EOC))
- Giulia Dazio
(Institute of Pathology, Ente Ospedaliero Cantonale (EOC))
- Francesco Marchi
(Neurocenter of the Southern Switzerland, Regional Hospital of Lugano)
- Paolo Spina
(Institute of Pathology, Ente Ospedaliero Cantonale (EOC)
University of Eastern Piedmont)
- Eva C. Arnspang
(University of Southern Denmark)
- Mette Soerensen
(University of Southern Denmark)
- Ulf Bech Christensen
(PentaBase A/S)
- Milo Frattini
(Institute of Pathology, Ente Ospedaliero Cantonale (EOC))
- Rasmus Koefoed Petersen
(PentaBase A/S)
Abstract
DNA methylation is important for gene expression and alterations in DNA methylation are involved in the development and progression of cancer and other major diseases. Analysis of DNA methylation patterns has until now been dependent on either a chemical or an enzymatic pre-treatment, which are both time consuming procedures and potentially biased due to incomplete treatment. We present a qPCR technology, EpiDirect®, that allows for direct PCR quantification of DNA methylations using untreated DNA. EpiDirect® is based on the ability of Intercalating Nucleic Acids (INA®) to differentiate between methylated and unmethylated cytosines in a special primer design. With this technology, we develop an assay to analyze the methylation status of a region of the MGMT promoter used in treatment selection and prognosis of glioblastoma patients. We compare the assay to two bisulfite-relying, methyl-specific PCR assays in a study involving 42 brain tumor FFPE samples, revealing high sensitivity, specificity, and the clinical utility of the method.
Suggested Citation
Kamilla Kolding Bendixen & Maria Mindegaard & Samantha Epistolio & Giulia Dazio & Francesco Marchi & Paolo Spina & Eva C. Arnspang & Mette Soerensen & Ulf Bech Christensen & Milo Frattini & Rasmus Koe, 2023.
"A qPCR technology for direct quantification of methylation in untreated DNA,"
Nature Communications, Nature, vol. 14(1), pages 1-11, December.
Handle:
RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-40873-y
DOI: 10.1038/s41467-023-40873-y
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-40873-y. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.